MENU
PVCT
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Provectus Biopharmaceuticals (PVCT) Ownership - Who owns Provectus Biopharmaceuticals?
Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases that are based on a class of synthetic small molecule immuno-catalysts called halogenated xanthenes (HXs)... Show more
Profile
Industry
N/A
Address
800 S Gay St
Phone
+1 866 594-5999
Employees
4
Web
https://www.provectusbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
41.9M
P/E Ratio
N/A
Total Cash
187.46K
Projected Growth
N/A
Total Debt
2.8M
Revenue
N/A
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PVCT
Capitalization
41.9M
P/E Ratio
N/A
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash
187K
Total Cash/Share
0.00
Total Debt
2.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-5.44M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
420K
Current Ratio
0.12
Current Revenue Per Employee
3.50
Dividends Per Share - Security
N/A
EBITDA
-2.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
35.71
Revenue To Assets
-243.06
Shares Held By Institutions
21.2K
Shares Outstanding - Current
420M
Total Liabilities
6.23M
Total Volume MTD
N/A
Value
1
Gain YTD
-16.986
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
800 S Gay St
Phone
+1 866 594-5999
Employees
4
Web
https://www.provectusbio.com